Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2003
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229108 Angiogenesis inhibitors; antitumor agents, anticancer agents
12/11/2003US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents
12/11/2003US20030229097 Potentiation of fungicides
12/11/2003US20030229096 Substituted imidazol-pyridazine derivatives
12/11/2003US20030229095 Sexual disorders
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229089 Cyclic compounds
12/11/2003US20030229084 Osteoporosis; antiarthritic agents
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229077 Nitrogen-containing heterocyclic compounds
12/11/2003US20030229074 Metabolism; eating disorders; sexual disorders
12/11/2003US20030229069 1-Sulfonyl-4-aminoalkoxy indole derivatives and uses thereof
12/11/2003US20030229068 Controlling apoptosis, cell proliferation; strokes; anticancer agents; central nervous system disorders
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders
12/11/2003US20030229025 Antidiabetic agents, eating disorders, dietetics
12/11/2003US20030229002 Use of agents that modulate PDE11A activity
12/11/2003US20030228983 Substituted aryl ketones
12/11/2003US20030228982 Substituted phenyl derivatives
12/11/2003CA2487675A1 Novel substituted indoles
12/11/2003CA2486530A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003CA2486110A1 Pharmaceutical combination
12/11/2003CA2485871A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/10/2003EP1368403A1 Polymers
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368337A2 Piperazine derivatives and their use as 5-ht1b ligands
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/10/2003EP1367888A2 Selective substituted aryl ketone and safener based herbicides
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461299A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
12/10/2003CN1130351C 1,5-benzodiazepine derivatives
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/09/2003US6660741 Coupling an O-protected methoxypyrrolidine or derivatives with N-protected amino acid 2,5-dioxo-pyrrolidinyl ester to form intermediate, deportecting with trifluoroacetic acid to form pyrrolidine-1-carbonyl-2-methylamine or derivatives
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction
12/09/2003US6660733 Induce immunology response
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003US6660465 Yellow coupler and silver halide color photographic lightsensitive material containing the same
12/09/2003US6660046 Cationic oxidation bases, their use of dyeing keratin fibres, dyeing compositions and dyeing methods
12/09/2003CA2189593C Sulphonylaminocarbonyltriazolinones having substituents bonded via oxygen
12/04/2003WO2003099818A1 Substituted quinazolinone compounds
12/04/2003WO2003099814A1 Calcium receptor modulating agents
12/04/2003WO2003099811A1 Kinase inhibitors
12/04/2003WO2003099809A1 HETEROCYCLIC COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY α4 INTEGRINS
12/04/2003WO2003099796A1 Protein kinase inhibitors
12/04/2003WO2003099793A1 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/04/2003WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003WO2003099765A1 β-ALANINE DERIVATIVE AND USE THEREOF
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099274A1 Hepatitis c virus inhibitors
12/04/2003WO2003099221A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003WO2003099211A2 Mitotic kinesin inhibitors
12/04/2003WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/04/2003WO2003063794A3 2,4-pyrimidinediamine compounds and their uses
12/04/2003WO2002094796A3 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
12/04/2003US20030225288 Small organic compounds to modulate chemokine receptor activity; treating psoriasis, autoimmune diseases, multiple sclerosis, graft rejection, infectious diseases; anti-allergen, -arthritic, -inflammatory, carcinogenic agents
12/04/2003US20030225271 Compounds useful as reversible inhibitors of cysteine proteases
12/04/2003US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225152 Such as 3-phenylaminomethylene-1,3-dihydroindol-2-one; use treating cancer, blood vessel proliferative disorders, fibrotic disorders, mesangial cell proliferative disorders and metabolic diseases
12/04/2003US20030225151 Pyrazole compositions useful as inhibitors of ERK
12/04/2003US20030225111 Use of a quinazoline derivative such as 1-(2,6-dichloro-phenyl)-3-(7-(3-morpholinopropoxy)quinazolin-4-yl) urea to produce an antiangiogenic and/or vascular permeability reducing effect
12/04/2003US20030225105 New linear cyclic ureas
12/04/2003US20030225102 Dipeptidyl peptidase inhibitors; heterocyclic amide and semicarbazide derivatives, e.g., (2-Cyano-1-(piperazine-2-yl)-carbonyl pyrrolidine bis-trifluoroacetate
12/04/2003US20030225090 Oxindole derivatives
12/04/2003US20030225082 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225073 Compositions useful as inhibitors of protein kinases
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225070 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/04/2003US20030225061 Protease inhibitors
12/04/2003US20030225057 3-Benzoazepine derivatives
12/04/2003US20030225053 N-arylcarboxamides of fused ring systems including naphthalenes, benzothiophenes, benzofurans and indoles
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030225042 Antipicornaviral compounds and compositions, their uses, and materials for their synthesis
12/04/2003CA2487315A1 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/04/2003CA2487073A1 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003CA2486966A1 Substituted quinazolinone compounds
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003CA2486187A1 Kinase inhibitors
12/04/2003CA2484288A1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/04/2003CA2483627A1 Mitotic kinesin inhibitors
12/03/2003EP1367056A1 Drugs that enhance synaptic responses mediated by AMPA receptors
12/03/2003EP1366760A1 Tablets quickly disintegrated in oral cavity
12/03/2003EP1366045A2 Efficient process for the preparation of a factor xa inhibitor
12/03/2003EP1366040A2 Amorphous form of cell cycle inhibitor
12/03/2003EP1366039A1 Piperazinylcarbonylquinolines and -isoquinolines
12/03/2003EP1224181B1 Substituted pyrroles as antiproliferative agents for the treatment of cancer
12/03/2003EP0973395B1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/03/2003EP0937070B1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
12/03/2003EP0693072B1 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes
1 ... 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 ... 626